Analysis, reports, chat and Advanced access use the same Rusaka Markets account. The backend remains authoritative for roles, subscriptions, credits and permissions.
Reported and computed values remain separate; missing values are not converted to zero.
Research path: Interpret Galaxy Surfactants's snapshot alongside the wider market dashboard, the financial-statement research guide and the valuation-ratios field guide.
Crosshair, OHLCV tooltip, indicators, volume, zoom and pan use the same candle API as the advanced workspace.
Calculated from validated daily candles. Descriptive research only.
Indicators describe price behaviour and volatility; they are not a BUY, NEUTRAL or SELL recommendation.
IND AS · INR crore
| Metric | 2026 | 2025 | 2024 |
|---|---|---|---|
| Total Liabilities Shareholders' Equity | 3,874.18 | 3,462.09 | 2,914.68 |
| Accumulated Depreciation Total | -1,049.96 | -888.63 | -798.42 |
| Cash Equivalents | 9.48 | 82.05 | 155.78 |
| Other Liabilities Total | 18.16 | 13.46 | 9.67 |
| Accrued Expenses | 0.57 | 0.08 | 0.31 |
| Long Term Debt | 5.71 | 17.13 | 45.68 |
| Common Stock Total | 35.45 | 35.45 | 35.45 |
| Other Equity Total | 268.1 | 146.71 | 123.7 |
| Other Current Assets Total | 1.21 | 14.36 | 1.23 |
| Prepaid Expenses | 18.29 | 13.52 | 11.91 |
| Total Assets | 3,874.18 | 3,462.09 | 2,914.68 |
| Current Portof LT Debt/Capital Leases | 24.73 | 23.92 | 46.42 |
| Additional Paid-In Capital | 0.2 | 0.2 | 0.2 |
| Cash | 99.64 | 111.36 | 64.68 |
| Total Equity | 2,744.83 | 2,362.54 | 2,179.25 |
| Long Term Investments | 4.72 | 8.72 | 2.32 |
| Retained Earnings(Accumulated Deficit) | 2,441.08 | 2,180.18 | 2,019.9 |
| Total Common Shares Outstanding | 3.55 | 3.55 | 3.55 |
| Property/Plant/Equipment Total-Gross | 2,396.76 | 2,174.57 | 1,922.47 |
| Tangible Book Valueper Share Common Eq | 771.83 | 664.56 | 612.56 |
| Goodwill Net | 3.44 | 3.1 | 3.03 |
| Total Liabilities | 1,129.35 | 1,099.55 | 735.43 |
| Total Debt | 235.47 | 210.28 | 187.42 |
| Short Term Investments | 643.95 | 315.84 | 217.68 |
| Cashand Short Term Investments | 753.07 | 509.25 | 438.14 |
| Total Receivables Net | 876.55 | 832.55 | 694.67 |
| Notes Payable/Short Term Debt | 147.35 | 110.42 | 47.99 |
| Deferred Income Tax | 31.39 | 31.84 | 29.65 |
| Accounts Receivable-Trade Net | 751.28 | 687.22 | 593.97 |
| Property/Plant/Equipment Total-Net | 1,346.8 | 1,285.94 | 1,124.05 |
| Total Current Liabilities | 1,016.41 | 978.31 | 603.1 |
| Total Inventory | 793.72 | 723.88 | 556.05 |
| Accounts Payable | 650.88 | 619.95 | 446.12 |
| Other Currentliabilities Total | 192.88 | 223.94 | 62.26 |
| Total Long Term Debt | 63.39 | 75.94 | 93.01 |
| Intangibles Net | 4.89 | 3.27 | 4.39 |
| Other Long Term Assets Total | 24.66 | 25.4 | 20.34 |
| Note Receivable-Long Term | 46.83 | 42.1 | 58.55 |
| Total Current Assets | 2,442.84 | 2,093.56 | 1,702 |
| Capital Lease Obligations | 57.68 | 58.81 | 47.33 |
Debt 5Yr CAGR %-4.03
Operating Margin 12m6.49
Operating Margin 5y Avg8.95
Net Profit Margin 12m5.09
Net Profit Margin 5y7.09
Dividend Yield %1.1
Price to Sale Ratio1.34
Overall RiskBalanced risk
Board Risk34.2
ConsensusBuy
Consensus score2.00
Analyst opinions11
Strong Sell count0
Sell count1
Hold count3
Buy count2
Strong Buy count5
Provider consensus uses a 1 (Strong Buy) to 5 (Strong Sell) score. The payload does not include price targets, so none are inferred from 52-week prices or recommendation percentages.Only peers present in the company profile payload are displayed.
| Company | Price | Market cap | P/E | Research |
|---|---|---|---|---|
| Asian Paints | INR 2,749 | 2.64 L | 58.09 | — |
| Solar Industries India | INR 18,560 | 1.68 L | 99.61 | — |
| Pidilite Industries | INR 1,671 | 1.70 L | 64.76 | — |
| SRF | INR 2,626 | 77,841.16 | 44.57 | — |
| Linde India | INR 7,105 | 61,033.66 | 110.53 | — |
Source, timestamp and external destination are shown. Provider relevance scores are not available.
Galaxy Surfactants: Domestic Gains vs. Global Challenges Whalesbook
Galaxy Surfactants: Domestic consumption trends holding up Moneycontrol.com
Galaxy Surfactants Yearly results, Financial Summary The Economic Times
Galaxy Surfactants Ltd Technical Momentum Shifts Amid Bearish Sentiment Markets Mojo
Galaxy Surfactants to attend ICICI Securities investor meet scanx.trade
Galaxy Surfactants Ltd is Rated Sell Markets Mojo
Posts are linked to the canonical company record. Community BUY, NEUTRAL and SELL opinions are user-generated, moderated and separate from analyst consensus and Rusaka Markets AI.
Galaxy Surfactants Limited is an India-based company. The Company provides surfactants and specialty services for the personal, home care, beauty and wellness industries. It offers emollients, fatty alcohol ethoxylates, fatty alcohol sulfates and ether sulfates; foam and viscosity boosters; functional actives, linear alkyl benzene sulfonic acid (LABSA), mild surfactant, pearlizers, preservatives and blends; sun protection, surfactant blends, syndet and transparent bathing bars. It offers GalMOL MOD, which is an emollient derived from renewable sources such as myristic acid and octyldodecanol. Its fatty alcohol ethoxylates include Galaxy MW 259, Galaxy MW 287, Galaxy MW 257, and Galaxy MW 253. Its fatty alcohol sulfates and ether sulfates include Galaxy 689, Galaxy 789 SP, Galaxy 796 G, Galaxy 799, and Galaxy ALS. The Company's foam and viscosity boosters include Galaxy CAPB DC, Galaxy CAPB Plus, Galaxy CB, Galaxy LAPB and Galaxy CAPB VB.
Galaxy Surfactants has the symbol GALAXYSURF and ISIN - INE600K01018.
Galaxy Surfactants is currently trading at INR 2,239.00.
Galaxy Surfactants has a year high of INR 2,648.00 and a year low of INR 1,510.00.
Galaxy Surfactants has a market capitalization of INR 7,047.78 crore.
Galaxy Surfactants has a P/E ratio of 16.15.
Galaxy Surfactants has a dividend yield of 1.10%.
Galaxy Surfactants has revenue of INR 5,248.28 crore, net income of INR 267.38 crore, and EPS of INR 78.04.
Galaxy Surfactants has a book value of INR 771.83.
Galaxy Surfactants has a debt-to-equity ratio of NA.
Galaxy Surfactants has a price-to-book ratio of 2.90 and a price-to-sales ratio of 1.34.
Corporate-action adjustment is provider-defined. Rusaka Markets research and computed indicators are not investment advice.